logo True scholar network
Back to Top
Visit Website

Expert Opinion on Emerging Drugs (EOED)

Publisher :

Taylor & Francis

Scopus Profile
Peer reviewed only
Scopus Profile
Open Access
  • the needs of pharmaceutical and academic scientists
  • research planners
  • pharmaceutical product managers

    • +4

e-ISSN :

1744-7623

Issue Frequency :

Quarterly

Impact Factor :

2.7

p-ISSN :

1472-8214

Est. Year :

1996

Mobile :

4402080520500

DOI :

YES

Country :

United Kingdom

Language :

English

APC :

YES

Impact Factor Assignee :

GOOGLE SCHOLAR

Email :

enquiries@taylorandfrancis.com

Journal Descriptions

Expert Opinion on Emerging Drugs [ISSN 1472-8214]; [e-ISSN 1744-7623] is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles and editorial pieces on Phase II and Phase III drugs/drug classes emerging onto the market across all therapy areas, providing expert opinion on their potential impact on the current management of specific diseases. Each article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development. Expert Opinion on Emerging Drugs addresses the needs of pharmaceutical and academic scientists, research planners, pharmaceutical product managers, clinical opinion leaders and healthcare planners. Articles include the following key areas: Concise background to the subject matter Assessment of medical need for alternative or novel therapies Assessment of the market and anticipated changes over time Summary of current research goals Outline of the scientific rationale for the approach(es) considered Analysis of the competitive environment Discussion of potential development issues The author’s expert opinion on the potential impact emerging therapies will have on the current management of specific diseases


Expert Opinion on Emerging Drugs (EOED) is :

International, Peer-Reviewed, Open Access, Refereed, the needs of pharmaceutical and academic scientists, research planners, pharmaceutical product managers, clinical opinion leaders, healthcare planners, Concise background to the subject matter, Summary of current research goals , Online or Print, Quarterly Journal

UGC Approved, ISSN Approved: P-ISSN - 1472-8214, E-ISSN - 1744-7623, Established in - 1996, Impact Factor - 2.7

Provide Crossref DOI

Indexed in Scopus, WoS

Not indexed in DOAJ, PubMed, UGC CARE

Indexing

Scopus Profile
Scopus
Scopus Profile
WoS
Scopus Profile
Crossref

+1 More

Establish Your Own Journal Without the Expense!

OJSCloud offers a complete, free setup to get you publishing.

Start Your Free Journal!
free profile